Product Information
MELOXICAM 5 MG CAPSULE is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $8.9225 per EA under NDC 70954007610. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Mar 9, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Meloxicam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954007610
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MELOXICAMApproval Type
Generic (ANDA)
FDA Application
ANDA211398FDA Approved
3/9/2021
TE Code
AB
On Market Since
3/10/2021
Pharmacological Classes
Price Statistics
The NADAC for MELOXICAM 5 MG CAPSULE has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 8.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.9225 per EA |
|---|---|
| All-time high | $14.4106 (Jul 16, 2025) |
| All-time low | $7.4004 (Jun 19, 2024) |
| 52-week high | $11.3931 |
| 52-week low | $8.2582 |
| Median price | $9.7116 |
| Average price | $9.9569 |
| Largest weekly change | +21.1% (Jul 17, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Meloxicam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MELOXICAM 5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MELOXICAM 5 MG CAPSULE, manufactured by ANI Pharmaceuticals, Inc., is $8.9225 per EA (NDC 70954007610), effective Sep 30, 2026.
How has the price of MELOXICAM 5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MELOXICAM 5 MG CAPSULE has declined 8.1%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for MELOXICAM 5 MG CAPSULE?
Since Apr 17, 2024, the NADAC for MELOXICAM 5 MG CAPSULE has ranged from a low of $7.4004 (Jun 19, 2024) to a high of $14.4106 (Jul 16, 2025), with a median of $9.7116 per EA.
Are there cheaper alternatives to MELOXICAM 5 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MELOXICAM 5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures MELOXICAM 5 MG CAPSULE?
MELOXICAM 5 MG CAPSULE (NDC 70954007610) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.